{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:50Z","timestamp":1792782470833,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Research Centre \u201cKurchatov Institute\u201d","id":[{"id":"https:\/\/ror.org\/02n85j827","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["Agreement 075-10-2025-017"],"award-info":[{"award-number":["Agreement 075-10-2025-017"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016971","name":"Lomonosov Moscow State University","doi-asserted-by":"publisher","award":["121021000105-7"],"award-info":[{"award-number":["121021000105-7"]}],"id":[{"id":"10.13039\/501100016971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016971","name":"Lomonosov Moscow State University","doi-asserted-by":"publisher","award":["121021000105-7"],"award-info":[{"award-number":["121021000105-7"]}],"id":[{"id":"10.13039\/501100016971","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Saint Petersburg State University, Russia","award":["125022102790-5"],"award-info":[{"award-number":["125022102790-5"]}],"id":[{"id":"https:\/\/ror.org\/023znxa73","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"DOI":"10.1007\/s00044-026-03615-5","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:28:01Z","timestamp":1790242081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peptide-based allosteric modulators of AMPA receptors: design, docking and ligand-receptor interactions"],"prefix":"10.1007","author":[{"given":"Tatiana V.","family":"Vyunova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila A.","family":"Andreeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin V.","family":"Shevchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriy P.","family":"Shevchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Y.","family":"Nagaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Butylin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mstislav I.","family":"Lavrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8792-8386","authenticated-orcid":false,"given":"Vladimir A.","family":"Palyulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel E.","family":"Musienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay F.","family":"Myasoedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"12","key":"3615_CR1","doi-asserted-by":"publisher","first-page":"9846","DOI":"10.3390\/ijms24129846","volume":"24","author":"KH Husain","year":"2023","unstructured":"Husain KH, Sarhan SF, AlKhalifa HKAA, Buhasan A, Moin ASM, Butler AE. Dementia in Diabetes: The Role of Hypoglycemia. Int J Mol Sci. 2023;24(12):9846. https:\/\/doi.org\/10.3390\/ijms24129846.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3615_CR2","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1001\/jamaneurol.2023.3664","volume":"80","author":"RC Petersen","year":"2023","unstructured":"Petersen RC, Weintraub S, Sabbagh M, Karlawish J, Adler ChH, Dilworth-Anderson P, Frank L, Hummel CH, Taylor AA. New Framework for Dementia Nomenclature. JAMA Neurol. 2023;80(12):1364\u201370. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3664.","journal-title":"JAMA Neurol"},{"issue":"10","key":"3615_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.amjmed.2018.01.022","volume":"131","author":"SA Gale","year":"2018","unstructured":"Gale SA, Acar D, Daffner KR, Dementia. Am J Med. 2018;131(10):1161\u20139. https:\/\/doi.org\/10.1016\/j.amjmed.2018.01.022.","journal-title":"Am J Med"},{"issue":"11","key":"3615_CR4","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1002\/alz.13363","volume":"19","author":"H Ulugut","year":"2023","unstructured":"Ulugut H, Pijnenburg YAL. Frontotemporal dementia: Past, present, and future. Alzheimer\u2019s Dement. 2023;19(11):5253\u201363. https:\/\/doi.org\/10.1002\/alz.13363.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"3615_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1017\/cjn.2022.69","volume":"50","author":"MC Tartaglia","year":"2023","unstructured":"Tartaglia MC, Mackenzie IRA. Recent Advances in Frontotemporal Dementia. Can J Neurol Sci. 2023;50(4):485\u201394. https:\/\/doi.org\/10.1017\/cjn.2022.69.","journal-title":"Can J Neurol Sci"},{"key":"3615_CR6","volume-title":"World Alzheimer Report 2015 \u2013 The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends","author":"MJ Prince","year":"2015","unstructured":"Prince MJ, Wimo A, Guerchet MM, Ali GC, Wu YT, Prina M. World Alzheimer Report 2015 \u2013 The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. London: Alzheimer\u2019s Disease International; 2015."},{"issue":"4","key":"3615_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/s-0033-1359320","volume":"33","author":"DK Kuruppu","year":"2013","unstructured":"Kuruppu DK, Matthews BR. Young-onset dementia. Semin Neurol. 2013;33(4):365\u201385. https:\/\/doi.org\/10.1055\/s-0033-1359320.","journal-title":"Semin Neurol"},{"key":"3615_CR8","doi-asserted-by":"publisher","first-page":"119129","DOI":"10.1016\/j.lfs.2021.119129","volume":"276","author":"ES Thoe","year":"2021","unstructured":"Thoe ES, Fauzi A, Tang YQ, Chamyuang S, Chia AYY. A review on advances of treatment modalities for Alzheimer\u2019s disease. Life Sci. 2021;276:119129. https:\/\/doi.org\/10.1016\/j.lfs.2021.119129.","journal-title":"Life Sci"},{"issue":"4","key":"3615_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.25259\/JNRP_356_2023","volume":"14","author":"A Varadharajan","year":"2023","unstructured":"Varadharajan A, Davis AD, Ghosh A, Jagtap T, Xavier A, Menon AJ, Roy D, Gandhi S, Gregor T. Guidelines for pharmacotherapy in Alzheimer\u2019s disease - A primer on FDA-approved drugs. J Neurosciences Rural Pract. 2023;14(4):566\u201373. https:\/\/doi.org\/10.25259\/JNRP_356_2023.","journal-title":"J Neurosciences Rural Pract"},{"issue":"1","key":"3615_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1017\/S1041610213001658","volume":"26","author":"AR Atti","year":"2014","unstructured":"Atti AR, Gozzi BF, Zuliani G, Bernabei V, Scudellari P, Berardi D, De Ronchi D, Tarricone I, Menchetti M. A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia. Int Psychogeriatr. 2014;26(1):19\u201337. https:\/\/doi.org\/10.1017\/S1041610213001658.","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"3615_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1358\/dot.2005.41.6.893628","volume":"41","author":"O Freudenreich","year":"2005","unstructured":"Freudenreich O. Drug-induced sialorrhea. Drugs Today. 2005;41(6):411\u20138. https:\/\/doi.org\/10.1358\/dot.2005.41.6.893628.","journal-title":"Drugs Today"},{"key":"3615_CR12","doi-asserted-by":"publisher","first-page":"1006989","DOI":"10.3389\/fncom.2022.1006989","volume":"16","author":"S Masoli","year":"2022","unstructured":"Masoli S, Rizza MF, Tognolina M, Prestori F, D\u2019Angelo E. Computational models of neurotransmission at cerebellar synapses unveil the impact on network computation. Front Comput Neurosci. 2022;16:1006989. https:\/\/doi.org\/10.3389\/fncom.2022.1006989.","journal-title":"Front Comput Neurosci"},{"issue":"1","key":"3615_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1113\/jphysiol.2009.179382","volume":"588","author":"N Rebola","year":"2010","unstructured":"Rebola N, Srikumar BN, Mulle C. Activity-dependent synaptic plasticity of NMDA receptors. J Physiol. 2010;588(1):93\u20139. https:\/\/doi.org\/10.1113\/jphysiol.2009.179382.","journal-title":"J Physiol"},{"key":"3615_CR14","doi-asserted-by":"publisher","first-page":"185463","DOI":"10.1155\/2013\/185463","volume":"2013","author":"Y Ota","year":"2013","unstructured":"Ota Y, Zanetti AT, Hallock RM. The Role of Astrocytes in the Regulation of Synaptic Plasticity and Memory Formation. Neural Plast. 2013;2013:185463. https:\/\/doi.org\/10.1155\/2013\/185463.","journal-title":"Neural Plast"},{"issue":"5","key":"3615_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1070\/RC2009v078n05ABEH004020","volume":"78","author":"VV Grigoriev","year":"2009","unstructured":"Grigoriev VV, Proshin AN, Kinzirsky AS, Bachurin SO. Modern approaches to the design of memory and cognitive function stimulants based on AMPA receptor ligands. Rus Chem Rev. 2009;78(5):485\u201394. https:\/\/doi.org\/10.1070\/RC2009v078n05ABEH004020.","journal-title":"Rus Chem Rev"},{"issue":"2","key":"3615_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.neuron.2018.10.018","volume":"100","author":"GH Diering","year":"2018","unstructured":"Diering GH, Huganir RL. The AMPA Receptor Code of Synaptic Plasticity. Neuron. 2018;100(2):314\u201329. https:\/\/doi.org\/10.1016\/j.neuron.2018.10.018.","journal-title":"Neuron"},{"issue":"8","key":"3615_CR17","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.neurom.2021.09.003","volume":"25","author":"JC Brown","year":"2022","unstructured":"Brown JC, Higgins ES, George MS. Synaptic Plasticity 101: The Story of the AMPA Receptor for the Brain Stimulation Practitioner. Neuromodulation. 2022;25(8):1289\u201398. https:\/\/doi.org\/10.1016\/j.neurom.2021.09.003.","journal-title":"Neuromodulation"},{"issue":"9","key":"3615_CR18","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.bcp.2005.12.022","volume":"71","author":"A Alt","year":"2006","unstructured":"Alt A, Nisenbaum ES, Bleakman D, Witkin JM. A role for AMPA receptors in mood disorders. Biochem Pharmacol. 2006;71(9):1273\u201388. https:\/\/doi.org\/10.1016\/j.bcp.2005.12.022.","journal-title":"Biochem Pharmacol"},{"key":"3615_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1134\/S160767291905003X","volume":"488","author":"VV Grigoriev","year":"2019","unstructured":"Grigoriev VV, Lavrov MI, Zamoyski VL, Garibova TL, Palyulin VA, Bachurin SO. A new positive allosteric modulator of AMPA receptors: in vitro and in vivo studies. Dokl Biochem Biophys. 2019;488:304\u20136. https:\/\/doi.org\/10.1134\/S160767291905003X.","journal-title":"Dokl Biochem Biophys"},{"key":"3615_CR20","unstructured":"Bachurin SO, Grigoriev VV, Palyulin VA, Lavrov MI, Zefirov NS, Garibova TL, Voronina TA, Roziev RA. N,N\u2019-substituted 3,7-diazabicyclo[3.3.1]nonanes, pharmaceutical compositions based thereon and use thereof. Patent RU 2613071, 2017 ;1-24."},{"issue":"1","key":"3615_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/biom13010056","volume":"13","author":"EA Golubeva","year":"2023","unstructured":"Golubeva EA, Lavrov MI, Radchenko EV, Palyulin VA. Diversity of AMPA receptor ligands: Chemotypes, binding modes, mechanisms of action, and therapeutic effects. Biomolecules. 2023;13(1):56. https:\/\/doi.org\/10.3390\/biom13010056.","journal-title":"Biomolecules"},{"issue":"3","key":"3615_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2174\/1874467213666200303140834","volume":"13","author":"TV Vyunova","year":"2020","unstructured":"Vyunova TV, Andreeva LA, Shevchenko KV, Grigoriev VV, Palyulin VA, Lavrov MI, Bondarenko EV, Kalashnikova EE, Myasoedov NF. Characterization of a New Positive Allosteric Modulator of AMPA Receptors - PAM-43: Specific Binding of the Ligand and its Ability to Potentiate AMPAR Currents. Curr Mol Pharmacol. 2020;13(3):216\u201323. https:\/\/doi.org\/10.2174\/1874467213666200303140834.","journal-title":"Curr Mol Pharmacol"},{"issue":"5","key":"3615_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s10517-006-0428-1","volume":"142","author":"VK Meshavkin","year":"2006","unstructured":"Meshavkin VK, Kost NV, Sokolov OY, Zolotarev YA, Myasoedov NF, Zozulya AA. Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system. Bull Exp Biol Med. 2006;142(5):598\u2013600. https:\/\/doi.org\/10.1007\/s10517-006-0428-1.","journal-title":"Bull Exp Biol Med"},{"issue":"6","key":"3615_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.17116\/jnevro20151156133-40","volume":"115","author":"VE Medvedev","year":"2015","unstructured":"Medvedev VE, Tereshchenko ON, Kost NV, Ter-Israelyan AY, Gushanskaya EV, Chobanu IK, Sokolov OY, Myasoedov NF. Optimization of the treatment of anxiety disorders with selank. Zhurnal Nevrologii i Psihiatrii imeni S S Korsakova. 2015;115(6):33\u201340. https:\/\/doi.org\/10.17116\/jnevro20151156133-40.","journal-title":"Zhurnal Nevrologii i Psihiatrii imeni S S Korsakova"},{"key":"3615_CR25","doi-asserted-by":"publisher","unstructured":"Kolomin T, Shadrina M, Slominsky P, Limborska S, Myasoedov N. New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides. Neurosci Med. 2013;44:223\u201352. https:\/\/doi.org\/10.4236\/nm.2013.44035.","DOI":"10.4236\/nm.2013.44035"},{"issue":"4","key":"3615_CR26","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1152\/jn.00436.2005","volume":"94","author":"M Pieri","year":"2005","unstructured":"Pieri M, Severini C, Amadoro G, Carunchio I, Barbato C, Ciotti MT, Zona C. AMPA receptors are modulated by tachykinins in rat cerebellum neurons. J Neurophysiol. 2005;94(4):2484\u201390. https:\/\/doi.org\/10.1152\/jn.00436.2005.","journal-title":"J Neurophysiol"},{"issue":"2","key":"3615_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0006-8993(94)01333-d","volume":"671","author":"M Kolaj","year":"1995","unstructured":"Kolaj M, Cerne R, Randic M. The opioid peptide dynorphin modulates AMPA and kainate responses in acutely isolated neurons from the dorsal horn. Brain Res. 1995;671(2):227\u201344. https:\/\/doi.org\/10.1016\/0006-8993(94)01333-d.","journal-title":"Brain Res"},{"key":"3615_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10517-009-0499-x","volume":"147","author":"VV Grigoriev","year":"2009","unstructured":"Grigoriev VV, Petrova LN, Ivanova TA, Gabreliyan AV, Serkova TP. Effect of Corticotropin-Like Intermediate Lobe Peptide on Presynaptic and Postsynaptic Glutamate Receptors and Postsynaptic GABA Receptors in Rat Brain. Bull Exp Biol Med. 2009;147:319\u201322. https:\/\/doi.org\/10.1007\/s10517-009-0499-x.","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"3615_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1134\/S160767291606003X","volume":"471","author":"TA Gudasheva","year":"2016","unstructured":"Gudasheva TA, Grigoriev VV, Koliasnikova KN, Zamoyski VL, Seredenin SB. Neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors. Doklady Biochem Biophys. 2016;471(1):387\u20139. https:\/\/doi.org\/10.1134\/S160767291606003X.","journal-title":"Doklady Biochem Biophys"},{"issue":"4","key":"3615_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pathophys.2004.10.001","volume":"11","author":"IP Ashmarin","year":"2005","unstructured":"Ashmarin IP, Samonina GE, Lyapina LA, Kamenskii AA, Levitskaya NG, Grivennikov IA, Dolotov OV, Andreeva LA, Myasoedov NF. Natural and hybrid (chimeric) stable regulatory glyproline peptides. Pathophysiology. 2005;11(4):179\u201385. https:\/\/doi.org\/10.1016\/j.pathophys.2004.10.001.","journal-title":"Pathophysiology"},{"issue":"1","key":"3615_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1381612823666170829135115","volume":"24","author":"VV Tarasov","year":"2018","unstructured":"Tarasov VV, Kudryashov NV, Chubarev VN, Kalinina TS, Barreto GE, Ashraf GM, Aliev G. Pharmacological Aspects of Neuro-Immune Interactions. Curr Pharm Design. 2018;24(1):15\u201321. https:\/\/doi.org\/10.2174\/1381612823666170829135115.","journal-title":"Curr Pharm Design"},{"issue":"17","key":"3615_CR32","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1002\/1873-3468.13855","volume":"594","author":"K Low","year":"2020","unstructured":"Low K, Roulin A, Kunz S. A proopiomelanocortin-derived peptide sequence enhances plasma stability of peptide drugs. FEBS Lett. 2020;594(17):2840\u201366. https:\/\/doi.org\/10.1002\/1873-3468.13855.","journal-title":"FEBS Lett"},{"issue":"2","key":"3615_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/molecules26020430","volume":"26","author":"V Apostolopoulos","year":"2021","unstructured":"Apostolopoulos V, Bojarska J, Chai T-T, Elnagdy S, Kaczmarek K, Matsoukas J, New R, Parang K, Lopez OP, Parhiz H, Perera CO, Pickholz M, Remko M, Saviano M, Skwarczynski M, Tang Y, Wolf WM, Yoshiya T, Zabrocki J, Zielenkiewicz P, AlKhazindar M, Barriga V, Kelaidonis K, Sarasia EM, Toth IA. Global Rev Short Peptides: Front Perspect Molecules. 2021;26(2):430. https:\/\/doi.org\/10.3390\/molecules26020430.","journal-title":"Global Rev Short Peptides: Front Perspect Molecules"},{"issue":"10","key":"3615_CR34","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3390\/ijms20102383","volume":"20","author":"AC-L Lee","year":"2019","unstructured":"Lee AC-L, Harris JL, Khanna KK, Hong J-H. A Comprehensive Review on Current Advances in Peptide Drug Development and Design. Int J Mol Sci. 2019;20(10):2383. https:\/\/doi.org\/10.3390\/ijms20102383.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3615_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mencom.2023.01.022","volume":"33","author":"EA Golubeva","year":"2023","unstructured":"Golubeva EA, Lavrov MI, Veremeeva PN, Bovina EM, Radchenko EV, Topchiy MA, Asachenko AF, Zamoyski VL, Grigoriev VV, Palyulin VA. New 1,11-dimethyl-3,6,9-triazatricyclo[7.3.1.13,11]tetradecane-4,8,12-trione derivative as an allosteric modulator of the glutamatergic system. Mendeleev Commun. 2023;33(1):70\u20132. https:\/\/doi.org\/10.1016\/j.mencom.2023.01.022.","journal-title":"Mendeleev Commun"},{"issue":"1","key":"3615_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12035-019-01768-6","volume":"57","author":"MI Lavrov","year":"2020","unstructured":"Lavrov MI, Karlov DS, Voronina TA, Grigoriev VV, Ustyugov AA, Bachurin SO, Palyulin VA. Novel positive allosteric modulators of AMPA receptors based on 3,7-diazabicyclo[3.3.1]nonane scaffold. Mol Neurobiol. 2020;57(1):191\u20139. https:\/\/doi.org\/10.1007\/s12035-019-01768-6.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"3615_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10930-025-10302-8","volume":"45","author":"M Cheshomi","year":"2026","unstructured":"Cheshomi M, Shobeiri N, Tajani AS, Khameneh B. Strategic Approaches for Overcoming Peptide and Protein Drug Limitations. Protein J. 2026;45(1):8\u201321. https:\/\/doi.org\/10.1007\/s10930-025-10302-8.","journal-title":"Protein J"},{"key":"3615_CR38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jconrel.2024.07.033","volume":"373","author":"H Hazam","year":"2024","unstructured":"Hazam H, Prades L, Cailleau C, Mougin J, Feng J, Benhamou D, Gobeaux F, Hamdi L, Couvreur P, Sitbon P, Lepetre-Mouelhi S. A nanomedicine approach for the treatment of long-lasting pain. J Controlled Release. 2024;373:688\u201398. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.033.","journal-title":"J Controlled Release"},{"issue":"5","key":"3615_CR39","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1021\/jm801397w","volume":"52","author":"L Zhang","year":"2009","unstructured":"Zhang L, Robertson CR, Green BR, Timothy H, Pruess H, Steve W, Grzegorz B. Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues. J Med Chem. 2009;52(5):1310\u20136. https:\/\/doi.org\/10.1021\/jm801397w.","journal-title":"J Med Chem"},{"key":"3615_CR40","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/S0196-9781(01)00537-X","volume":"22","author":"KA Witt","year":"2001","unstructured":"Witt KA, Gillespie TJ, Huber JD, Egleton RD, Davis TP. Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. Peptides. 2001;22:2329\u201343. https:\/\/doi.org\/10.1016\/S0196-9781(01)00537-X.","journal-title":"Peptides"},{"key":"3615_CR41","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0893-133X(02)00369-X","volume":"27","author":"K Lieb","year":"2002","unstructured":"Lieb K, Ahlvers K, Dancker K, Strohbusch S, Reincke M, Feige B, Berger M, Riemann D, Voderholzer U. Effects of the Neuropeptide Substance P on Sleep, Mood, and Neuroendocrine Measures in Healthy Young Men. Neuropsychopharmacol. 2002;27:1041\u20139. https:\/\/doi.org\/10.1016\/S0893-133X(02)00369-X.","journal-title":"Neuropsychopharmacol"},{"issue":"1","key":"3615_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1006\/exnr.2000.7580","volume":"168","author":"KF Hauser","year":"2001","unstructured":"Hauser KF, Knapp PE, Turbek CS. Structure\u2013Activity Analysis of Dynorphin A Toxicity in Spinal Cord Neurons: Intrinsic Neurotoxicity of Dynorphin A and Its Carboxyl-Terminal, Nonopioid Metabolites. Exp Neurol. 2001;168(1):78\u201387. https:\/\/doi.org\/10.1006\/exnr.2000.7580.","journal-title":"Exp Neurol"},{"issue":"4","key":"3615_CR43","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuroscience.2003.08.033","volume":"122","author":"IN Singh","year":"2003","unstructured":"Singh IN, Goody RJ, Goebel SM, Martin KM, Knapp PE, Marinova Z, Hirschberg D, Yakovleva T, Bergman T, Bakalkin G, Hauser KF. Dynorphin A (1\u201317) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate\/kainate receptor-mediated cytochrome c release and caspase-3 activation. Neuroscience. 2003;122(4):1013\u201323. https:\/\/doi.org\/10.1016\/j.neuroscience.2003.08.033.","journal-title":"Neuroscience"},{"issue":"3","key":"3615_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/s0306-4522(02)00563-8","volume":"116","author":"RJ Goody","year":"2003","unstructured":"Goody RJ, Martin KM, Goebel SM, Hauser KF. Dynorphin A toxicity in striatal neurons via an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate\/kainate receptor mechanism. Neuroscience. 2003;116(3):807\u201316. https:\/\/doi.org\/10.1016\/s0306-4522(02)00563-8.","journal-title":"Neuroscience"},{"issue":"1","key":"3615_CR45","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbrc.2010.04.001","volume":"396","author":"L Terenius","year":"2010","unstructured":"Terenius L, Johansson B. The opioid systems \u2013 panacea and nemesis. Biochem Biophys Res Commun. 2010;396(1):140\u20132. https:\/\/doi.org\/10.1016\/j.bbrc.2010.04.001.","journal-title":"Biochem Biophys Res Commun"},{"key":"3615_CR46","doi-asserted-by":"publisher","unstructured":"Lohman RJ, Reddy TK, Kandale A, Cabot PJ, Parekh HS. Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy. Front Pharmacol. 2023;141150313. https:\/\/doi.org\/10.3389\/fphar.2023.1150313.","DOI":"10.3389\/fphar.2023.1150313"},{"key":"3615_CR47","unstructured":"Tris Pharma, Inc. Phase 1 Intranasal Human Abuse Potential (HAP) Study of Cebranopadol: press release \/ Tris Pharma, Inc. \u2013 Monmouth Junction, NJ. 2025. \u2013 June 12. \u2013 URL: https:\/\/www.trispharma.com\/tris-pharma-debut-intranasal-results-cpdd-2025\/ (date of access: 04.05.2026)."},{"issue":"1","key":"3615_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mencom.2018.01.021","volume":"28","author":"KV Nagaev IYu, Shevchenko","year":"2018","unstructured":"Nagaev IYu, Shevchenko KV, Shevchenko VP, Myasoedov NF, Grigoriev VV, Lavrov MI, Bondarenko EV, Kalashnikova EE. Synthesis of tritium-labeled PAM-43. Mendeleev Commun. 2018;28(1):64\u20135. https:\/\/doi.org\/10.1016\/j.mencom.2018.01.021.","journal-title":"Mendeleev Commun"},{"key":"3615_CR49","unstructured":"Myasoedov NF, Nagaev IYu, Shevchenko KV, Shevchenko VP, Grigoriev VV, Lavrov MI,Bondarenko EV, Kalashnikova EE. Tritiated 3,7-bis(2,3-dihydro-1-benzofuran-5-ylcarbonyl)-1,5-dimethyl-3,7-diazabicyclo[3.3.1]nonan-9-one. Patent RU 2668982, 2018 ; 1-19."},{"key":"3615_CR50","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/cbdd.14221","volume":"101","author":"TV Vyunova","year":"2023","unstructured":"Vyunova TV, Andreeva LA, Shevchenko KV, Glazova NY, Sebentsova EA, Levitskaya NG, Myasoedov NF. Synthetic corticotropins and the GABA-receptor system: Direct and delayed effects. Chem Biol Drug Des. 2023;101:1393\u2013405. https:\/\/doi.org\/10.1111\/cbdd.14221.","journal-title":"Chem Biol Drug Des"},{"issue":"16","key":"3615_CR51","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785\u201391. https:\/\/doi.org\/10.1002\/jcc.21256.","journal-title":"J Comput Chem"},{"key":"3615_CR52","first-page":"474","volume":"9","author":"C Wellock","year":"2001","unstructured":"Wellock C, Ross BJ. An examination of Lamarckian genetic algorithms. Genetic Evolutionary Comput Conf Late Breaking Papers. 2001;9:474\u201381.","journal-title":"Genetic Evolutionary Comput Conf Late Breaking Papers"},{"key":"3615_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminformatics. 2012;4:17. https:\/\/doi.org\/10.1186\/1758-2946-4-17.","journal-title":"J Cheminformatics"},{"key":"3615_CR54","unstructured":"The PyMOL Molecular Graphics System, Version 3.0 Schr\u00f6dinger, LLC, https:\/\/pymol.org. (25.12.2025)"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03615-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:28:05Z","timestamp":1790242085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03615-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":54,"alternative-id":["3615"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03615-5","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were performed in accordance with Directive 2010\/63\/EU of the European Parliament and of the Council of the European Union on the protection of animals used for scientific purposes, and were approved by the Bioethics Committee of the National Research Centre \"Kurchatov Institute\" (Protocol No. 22\/5 dated December 16, 2022).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}